Crossover Trial to Assess Efficacy and Safety of Inhaled AQ001S Compared to a Budesonide Suspension in Mild Asthmatics
Status:
Recruiting
Trial end date:
2021-11-01
Target enrollment:
Participant gender:
Summary
This is a prospective, active-controlled, randomized, open label, single-center, multiple
dose, two-period crossover clinical trial to assess the efficacy, safety and pharmacokinetics
of AQ001S compared to a budesonide inhalation suspension (comparator) in adults with mild
asthma.
Both treatments will be administered by nebulization.